Skip to main content
Premium Trial:

Request an Annual Quote

UCB, Harvard Collaborate on Human Microbiome Research

NEW YORK (GenomeWeb News) – UCB today announced a collaboration with researchers at Harvard to study the human microbiome in the intestine.

The project, for which UCB is providing up to $4.5 million in funding over three years, will classify new species found in the human microbiome and study their impact on the immune system. The goal is to identify new drugs for preventing and/or treating immunological diseases.

Christophe Benoist, Dennis Kasper, and Diane Mathis, all professors in the division of immunology in the department of microbiology and immunology at Harvard Medical School, will head the project called "Mining the Human Microbiome."

They plan to mine the human microbiome for new immunomodulatory molecules found in the intestine with potential therapeutic applications and have designed an interdisciplinary project using technological advances in next-generation sequencing, whole-genome and single molecule transcript profiling, and polychromatic flow cytometry.

"We hope this project will fundamentally shift the paradigm of drug development for immunological diseases, exploiting naturally occurring molecules evolutionarily designed to thwart or harness the immune system," the Harvard researchers said in a statement. "If found, these molecules would be of enormous potential for probing immune system function, therapeutic application, and as a preventative therapy."

Belgian biopharmaceutical firm UCB and Harvard signed an Innovative Research Alliance in 2011, and the microbiome project is the third collaboration between the two parties.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.